Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
ZESTRIL
Generic name / active ingredient
lisinopril
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-09-04

Copy from the pack in hand

Source-linked reading points

  • Check ZESTRIL, lisinopril, oral-tablet form, the stated 2.5/5/10/20/30/40 mg per tablet, NDC, actual pack and target market together. Mg is the labelled amount in an exact tablet, not a web rule for how many tablets an individual should use, and it cannot self-convert another strength, form, market or medicine.
  • The label carries a pregnancy-related boxed warning. Questions about pregnancy, possible pregnancy, family planning or breastfeeding cannot be handled from a pack, webpage or another person's experience; contact the prescribing team or pharmacist promptly and check the exact product and current target-market label.
  • The label identifies kidney function, potassium, blood pressure, angioedema, and relationships with diuretics, NSAIDs, lithium, mTOR inhibitors or neprilysin inhibitors as safety cues requiring professional review. When adding a prescription, OTC pain/cold product, herb, supplement or salt substitute, have a pharmacist or care team check the complete medicine list and actual packs; do not self-combine, replace or alter use.
  • ZESTRIL contains lisinopril alone; ZESTORETIC already contains lisinopril and hydrochlorothiazide. The current label also states a 36-hour boundary around switching to or from sacubitril/valsartan. If both names appear or a switch involving ENTRESTO is planned, do not add, stop or schedule an interval from the website; contact the prescriber or pharmacist promptly.

Reviewed presentation examples — compare every field

  • 2.5 mg per tablet; 90-tablet bottleNDC 24979-238-07
  • 5 mg per tablet; 90-tablet bottleNDC 24979-239-07
  • 10 mg per tablet; 90-tablet bottleNDC 24979-240-07
  • 20 mg per tablet; 90-tablet bottleNDC 24979-241-07
  • 30 mg per tablet; 90-tablet bottleNDC 24979-242-07
  • 40 mg per tablet; 90-tablet bottleNDC 24979-243-07

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-04
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image